Cormorant Asset Management, LP Myovant Sciences Ltd. Transaction History

Cormorant Asset Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.31 - $23.87 $4.29 Million - $7.16 Million	-300,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$18.94 - $26.99 $4.59 Million - $6.55 Million	-242,499 Reduced 44.7%	300,000 $6.73 Million
Q2 2021 Aug 16, 2021	SELL	$17.07 - $24.56 $7.81 Million - $11.2 Million	-457,501 Reduced 45.75%	542,499 $12.4 Million
Q1 2021 May 17, 2021	SELL	$20.46 - $25.18 $14.3 Million - $17.6 Million	-700,000 Reduced 41.18%	1,000,000 $20.6 Million
Q4 2020 Feb 16, 2021	SELL	$13.8 - $27.62 $6 Million - $12 Million	-434,966 Reduced 20.37%	1,700,000 $47 Million
Q3 2020 Nov 16, 2020	SELL	$14.05 - $22.6 $5.13 Million - $8.25 Million	-365,034 Reduced 14.6%	2,134,966 $30 Million
Q2 2020 Aug 14, 2020	SELL	$7.34 - $20.84 $734,000 - $2.08 Million	-100,000 Reduced 3.85%	2,500,000 $51.6 Million
Q1 2020 May 15, 2020	BUY	$6.55 - $14.76 $3.93 Million - $8.86 Million	600,000 Added 30.0%	2,600,000 $19.6 Million
Q4 2019 Feb 14, 2020	BUY	$4.2 - $19.21 $8.4 Million - $38.4 Million	2,000,000 New	2,000,000 $31 Million
Q2 2019 Aug 14, 2019	SELL	$8.69 - $25.0 $5.65 Million - $16.3 Million	-650,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$16.83 - $24.45 $10.9 Million - $15.9 Million	650,000 New	650,000 $15.5 Million

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.